Bank Of America Corp Exicure, Inc. Transaction History

Bank Of America Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.3 - $0.64 $3,821 - $8,151	-12,737 Reduced 99.51%	63 $0
Q1 2024 May 15, 2024	BUY	$0.53 - $0.84 $6,784 - $10,752	12,800 New	12,800 $7,000
Q3 2022 Nov 14, 2022	BUY	$1.53 - $8.5 $4,127 - $22,933	2,698 New	2,698 $4,000

287K

Ticker XCUR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,962,580
Market Cap $92.7M
Description
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.